Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation.

Journal of the American College of Cardiology

Volumn 53, Issue 24, 2009, Pages 2298-2305

  Ota, Hidetaka ^a   Eto, Masato ^a   Ako, Junya ^a   Ogawa, Sumito ^a   Iijima, Katsuya ^a   Akishita, Masahiro ^a   Ouchi, Yasuyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; NOS3 PROTEIN, HUMAN; PACLITAXEL; PLASMINOGEN ACTIVATOR INHIBITOR 1; RAPAMYCIN; SIRT1 PROTEIN, HUMAN; SIRTUIN; TETRAZOLE DERIVATIVE; TICLOPIDINE; VASODILATOR AGENT;

ARTICLE; CELL AGING; COMPARATIVE STUDY; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG ELUTING STENT; GENETICS; HUMAN; METABOLISM; OXIDATIVE STRESS; VASCULAR ENDOTHELIUM;

ASPIRIN; CELL AGING; DOWN-REGULATION; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PACLITAXEL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET AGGREGATION INHIBITORS; SIROLIMUS; SIRTUINS; TETRAZOLES; TICLOPIDINE; VASODILATOR AGENTS;

EID: 67649983650     PISSN: None     EISSN: 15583597     Source Type: Journal    
DOI: None     Document Type: Article

References (0)